DENTSPLY SIRONA Inc.

XRAY | NASDAQ

Price Alert Chart Builder DCF Calculator

$9.87

+$0.34 (+3.57%)

Nov 2, 2026, 10:24 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+3.57%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

49.9

+7.5 pts

Fundamentals Average

Market Sentiment Neutral

Moat Narrow

Sector Rank #280/1028 (Top 27%)

Full Analysis

Key Statistics

Market Data

Market Cap $1.97B

1D Range

9.62 9.96

52W Range

8.42 14.68

Valuation (TTM)

PE -3.48

PB 1.41

EV/EBITDA 23.10

Valuation (NTM)

Forward PE 6.43

Forward PEG 0.75

Price Target $12.14

Cash Flow

FCF Yield 7.5%

SBC Adj. FCF Yield 5.9%

SBC Impact -21.7%

Margins

Gross Margin 49.5%

Operating Margin 11.7%

FCF Margin 3.9%

Growth (CAGR)

Revenue 3Y | 5Y -2.5% | -2.1%

Dil EPS 3Y | 5Y -33.5% | -36.3%

FCF 3Y | 5Y -10.3% | -25.7%

Returns

ROA -10.5%

ROE -39.8%

ROIC 10.0%

Financial Health

Net Debt

$1.99B

Current Ratio 1.63

Interest Coverage 4.68

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide....

Sector Healthcare

Industry Medical - Instruments & Supplies

Employees 14,000

IPO Date Aug 12, 1987

Website www.dentsplysirona.com

Fiscal Year January - December

Full Company Profile

Latest News

5 days ago · prnewswire.com

Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

13 days ago · globenewswire.com

Dentsply Sirona to Host Third Quarter 2026 Conference Call on November 5

CHARLOTTE, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, November 5, 2026, at 4:30 p.m. EST to review its third quarter 2026 financial results. Financial earnings materials will be made available on the Investors section of the Company's website at https://investor.dentsplysirona.com prior to the call.

26 days ago · globenewswire.com

Wellspect HealthCare Announces U.S. Medicare Reimbursement Access for Surity™ Urinary Management Portfolio

MÖLNDAL, Sweden, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Wellspect HealthCare today announced that the Surity™ portfolio, including the Surity™ Urinary Management System and Surity™ Female and Male External Catheters, may be covered by traditional Medicare for eligible beneficiaries when medically necessary. This milestone represents an important step in expanding access and reducing barriers to at-home management for people affected by severe urinary incontinence in the U.S.

2 months ago · zacks.com

Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for Now

XRAY's digital dentistry, R&D and restructuring support growth, but CAD/CAM, implants, SureSmile and tariff pressures pose near-term risks.

2 months ago · zacks.com

XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure

XRAY beat Q2 earnings and revenue estimates, held 2026 guidance and improved cash flow, but falling sales and margin pressure cloud the recovery.

3 months ago · prnewswire.com

New At-Home Surity™ Urinary Management System Designed to Provide Comfort and Reliable Care for People Living with Urinary Incontinence

New system completes the Surity™ portfolio of external catheters for both men and women Integrates into daily routines to help support management of urinary incontinence at home Designed to operate quietly overnight, new Surity™ System helps minimize nighttime interruptions to support comfort and rest MÖLNDAL, Sweden, Aug. 19, 2026 /PRNewswire/ -- Wellspect HealthCare today announced the U.S. launch of the Surity™ Urinary Management System, a discreet at-home urine collection device designed to support people living with urinary incontinence and those who help care for them. This completes the full Surity™ portfolio in the U.S., following the introduction of the Surity™ Female and Male External Catheters earlier this year.

3 months ago · marketbeat.com

DENTSPLY SIRONA Q2 Earnings Call Highlights

DENTSPLY SIRONA NASDAQ: XRAY reported second-quarter 2026 revenue of $898 million, down 4.1% on a reported basis and 6.3% on a constant-currency basis, as the dental products company continued its turnaround plan amid lower volumes in several businesses and distributor inventory reductions in Europe.

3 months ago · zacks.com

XRAY Stock Falls Despite Q2 Earnings Beat, Wellspect Drives Sales

DENTSPLY SIRONA's Q2 sales fall 4.1% as dental weakness offsets Wellspect growth, while margins improve and 2026 guidance is maintained.

3 months ago · zacks.com

Here's What Key Metrics Tell Us About Dentsply (XRAY) Q2 Earnings

The headline numbers for Dentsply (XRAY) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.